Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified the process by which stem cells in the airways of the lungs switch between two distinct phases—creating ...
Jul 28, 2020
0
78
New UCLA research conducted in mice could explain why some people suffer more extensive scarring than others after a heart attack. The study, published in the journal Cell, reveals that a protein known as type 5 collagen ...
Jul 6, 2020
0
87
Researchers at Karolinska Institutet in Sweden have developed a new method for analyzing intact tumor samples in 3-D on a molecular level. The study is a collaboration with Karolinska University Hospital and is published ...
Jun 30, 2020
0
202
Mutations in white blood cells can contribute to abnormal immune profile after hematopoietic stem cell transplantation.
May 7, 2020
0
53
A drug that is well-tolerated in patients and prevents cancer coming back in mice has been identified by researchers at the Francis Crick Institute.
Apr 14, 2020
0
368
Colorectal cancer kills more than 50,000 people a year in the United States alone, but scientists have struggled to find the exact mechanisms that trigger the growth of tumors in the intestine.
Apr 2, 2020
0
138
A new study by members of the Cumming School of Medicine (CSM) at the University of Calgary finds niacin, commonly called vitamin B3, combined with chemotherapy can help immune cells attack glioblastoma (a type of brain tumor), ...
Apr 2, 2020
0
262
The survival rates for patients with non-small cell lung cancer (NSCLC) have improved greatly over the past decade thanks to several new targeted treatment options for patients. However, lung cancer still remains the number ...
Mar 26, 2020
0
163
The deadly brain cancer glioblastoma (GBM) is often resistant to chemotherapy and radiation, but new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center shows ...
Feb 26, 2020
0
87
Scientists at the MDC have discovered stem cells responsible for the most common form of kidney cancer. The team of Walter Birchmeier has found a way to block the growth of these tumors in three models of the disease.
Feb 17, 2020
0
581
